Superoxide dismutase: an emerging target for cancer therapeutics

Author： Hileman Elizabeth A Achanta Geetha Huang Peng

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.5, Iss.6, 2001-12, pp. : 697-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Superoxide dismutase mimics as future therapeutics

By Henke S.L.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 169-180

Informa Healthcare

Access to resources Recommend Favorite

Mitochondrial Superoxide Dismutase: A Promising Target for New Anticancer Therapies

Current Medicinal Chemistry, Vol. 11, Iss. 10, 2004-05 ,pp. : 1299-1308

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutics for primary peritoneal cancer

By Slomovitz Brian M Worley Michael J Markman Maurie Coleman Robert L

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 1, 2011-03 ,pp. : 71-84

Informa Healthcare

Access to resources Recommend Favorite

Proteasome as an Emerging Therapeutic Target in Cancer

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 471-485

Bentham Science Publishers

Access to resources Recommend Favorite

Rationale for Ras and Raf-kinase as a Target for Cancer Therapeutics

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2231-2242

Bentham Science Publishers

Access to resources Recommend Favorite